Nothing Special   »   [go: up one dir, main page]

AU4698900A - Pharmaceutical compositions for treating malaria - Google Patents

Pharmaceutical compositions for treating malaria

Info

Publication number
AU4698900A
AU4698900A AU46989/00A AU4698900A AU4698900A AU 4698900 A AU4698900 A AU 4698900A AU 46989/00 A AU46989/00 A AU 46989/00A AU 4698900 A AU4698900 A AU 4698900A AU 4698900 A AU4698900 A AU 4698900A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
treating malaria
malaria
treating
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46989/00A
Inventor
Steven J. Barbee
Jon R. Geiger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arch Chemicals Inc
Original Assignee
Arch Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arch Chemicals Inc filed Critical Arch Chemicals Inc
Publication of AU4698900A publication Critical patent/AU4698900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU46989/00A 1999-05-07 2000-05-04 Pharmaceutical compositions for treating malaria Abandoned AU4698900A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13319799P 1999-05-07 1999-05-07
US60133197 1999-05-07
US56382400A 2000-05-03 2000-05-03
US09563824 2000-05-03
PCT/US2000/012148 WO2000067699A2 (en) 1999-05-07 2000-05-04 Pharmaceutical compositions for treating malaria

Publications (1)

Publication Number Publication Date
AU4698900A true AU4698900A (en) 2000-11-21

Family

ID=26831157

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46989/00A Abandoned AU4698900A (en) 1999-05-07 2000-05-04 Pharmaceutical compositions for treating malaria

Country Status (2)

Country Link
AU (1) AU4698900A (en)
WO (1) WO2000067699A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022533085A (en) 2019-05-14 2022-07-21 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Hair care composition containing 2 (1H) -pyridinone and piroctone olamine
CN114096230B (en) * 2019-05-14 2023-08-29 联合利华知识产权控股有限公司 2 (1H) -pyridones and their use for treating inflammatory conditions
JP7038448B1 (en) 2021-07-19 2022-03-18 雅行 沼田 Anti-allergic administration device
WO2023245258A1 (en) * 2022-06-24 2023-12-28 Griffith University Entry-modulating agents and uses therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9209078D0 (en) * 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions

Also Published As

Publication number Publication date
WO2000067699A3 (en) 2003-02-06
WO2000067699A2 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
HUP0202513A2 (en) Betha-carboline pharmaceutical compositions
AU1071301A (en) Pharmaceutical compounds
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
AU3192700A (en) Medicinal compositions
PL351387A1 (en) Pharmaceutical composition
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
ZA200109236B (en) Pharmaceutical compositions of erythropoietin.
AU3556400A (en) Pharmaceutical compositions
GB9923436D0 (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
AU1735001A (en) Cyclodextrin-containing pharmaceutical composition
AU1887401A (en) Medicinal composition
GB9904163D0 (en) Pharmaceutical compositions
AU4304400A (en) Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
AU5460800A (en) Pharmaceutical transdermal compositions
AU6460400A (en) Pharmaceutical compositions
AU2001273919A1 (en) Pharmaceutical compositions
GB9911017D0 (en) Pharmaceutical compositions
AU2681500A (en) Rapidly-soluble compositions
AU6460200A (en) Pharmaceutical compositions
AU5722900A (en) Pharmaceutical compounds
AU5085300A (en) Compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase